StockData
Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc. (NAUT) stock

NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 6/30
$2.36+0.26 (+12.38%)

Close on Nov 17, 2026Market cap $300.60MP/E –Yield –

Nautilus Biotechnology enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Nautilus Biotechnology's enterprise value was $223.88M on Nov 11, 2026, against $152.79M a year earlier. Over the last 5 years it ranged from -$62.01M to $387.30M, with a median of $141.72M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$223.88M+94.9%
2025Dec 31, 2025$114.89M+63.3%
2024Dec 31, 2024$70.34M-63.0%
2023Dec 29, 2023$190.27M–
2022Dec 30, 2022-$33.50M-111.3%
2021Dec 31, 2021$295.88M–

More Nautilus Biotechnology figures

See a number that looks wrong?